Prognostic Factors of Stage IV Epithelial Ovarian Cancer: A Multicenter Retrospective Study
- 1 June 2001
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 81 (3) , 398-403
- https://doi.org/10.1006/gyno.2001.6172
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Stage IV Ovarian Cancer: Impact of Surgical Debulking1Gynecologic Oncology, 1997
- Cytoreductive Surgery for the Management of Stage IV Ovarian CancerGynecologic Oncology, 1997
- Prognostic Significance of Residual Disease in Patients with Stage IV Epithelial Ovarian CancerGynecologic Oncology, 1997
- Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapyCancer, 1996
- Neoadjuvant chemotherapy for advanced ovarian cancerInternational Journal of Gynecologic Cancer, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Long-Term Survival in Advanced Ovarian Cancer after Cytoreduction and Chemotherapy TreatmentGynecologic Oncology, 1994
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaGynecologic Oncology, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958